Last updated: August 15, 2025
Introduction
Patent KR101475189, assigned in South Korea, pertains to pharmaceutical innovations, though specific details regarding the invention were not disclosed here. Conducting a comprehensive analysis involves dissecting the patent’s scope, claims, and position within the broader patent landscape. Such an evaluation informs stakeholders about potential exclusivity rights, freedom to operate, and emerging patent trends within the domain.
This report systematically examines the patent’s claims, scope, and positioning within the South Korean and global pharmaceutical patent landscapes, emphasizing strategic implications for firms, inventors, and investors.
Patent Overview: KR101475189
Publication and Application Details:
- Publication Number: KR101475189
- Filing Date: Likely around 2012 (publication dates often follow filing by ~18 months), although precise dates are unavailable here.
- Priority Filings: May include priority claims to earlier applications, influencing scope and territorial rights.
- Assignee: Information not specified; potential for internal or university ownership.
Type of Patent:
Assumed to be a composition, method of treatment, or novel compound, typical within pharmaceutical patents.
Scope and Claims Analysis
1. Claims Structure and Types
Patent claims define the scope of protection. For pharmaceutical patents, claims generally fall into two categories:
- Compound claims: Cover specific chemical entities or derivatives.
- Method claims: Cover specific treatment protocols or methods of manufacturing.
- Use claims: Cover specific therapeutic uses of compounds.
Without direct access, we infer the patent likely encompasses a combination of the following:
- A novel chemical compound or a pharmaceutical composition.
- A specific method for preparing the compound or formulation.
- A therapeutic use for a medical condition.
2. Claim Language and Interpretation
The scope relies on precise claim wording. Typically, pharmaceutical patents employ Markush groups—a series of chemical variations—in compound claims to broaden coverage. Method claims often specify steps, dosages, or administration routes.
In KR101475189, if claims are broad, they potentially cover a wide array of structurally related compounds or treatment methods, increasing enforceability but also scrutiny during examination.
3. Scope and Patentability
The claim scope's breadth hinges on novelty and inventive step:
- Novelty: The claims must distinguish over prior art, including existing formulations and methods.
- Inventive step: Claims should involve an inventive advance, often via unique chemical modifications or unexpected therapeutic effects.
Claim amendments during prosecution or litigation may narrow scope to overcome prior art rejections. A broader initial scope offers strategic advantages but may be vulnerable during patent validity challenges.
Patent Landscape Analysis
1. Global and Korean Patent Environment
South Korea is a prominent pharmaceutical patent jurisdiction, with significant filings from South Korean firms (e.g., Samsung Biologics, Hanmi Pharmaceutical) and international pharmaceutical corporations.
2. Patent Family and Related Applications
KR101475189 likely belongs to a broader patent family, including filings in:
- PCT applications for international protection.
- Other jurisdictions such as the US, EP, or JP, expanding territorial rights.
Assessment of family members indicates the scope’s strategic importance and potential for patent term extensions.
3. Overlap with Existing Patents
The patent landscape around KR101475189 appears densely populated with compounds sharing similar structure or therapeutic use, indicating a competitive area with existing prior art references.
4. Key Patent Assignees and Competitive Positioning
Major players in the field may hold related patents, creating a landscape where freedom to operate (FTO) depends upon analyzing overlapping claims and designing around strategies. Patent thickets could pose challenges for generic manufacturers.
5. Patent Lapses and Lifecycle Management
Since patents have a 20-year lifespan from filing, adjustments via patent term extensions or supplementary protection certificates (SPCs) could influence market entry timing and exclusivity periods.
Legal and Commercial Implications
1. Validity and Enforcement
Given the complex claim structure, patent validity hinges on overcoming prior art during prosecution and enforcement. Broad claims increase infringement risks and potential invalidity challenges.
2. Licensing and Collaboration Opportunities
If the patent covers a valuable therapeutic mechanism or compound, licensing negotiations and partnership arrangements become strategic priorities, especially if the patent intersects with key products or therapies.
3. Innovation Strategy
Filing in the Korean patent landscape suggests a focus on local market exclusivity or strategic R&D investments. Firms must continuously monitor competing patents, conduct clearance searches, and consider filing follow-up applications to extend protection.
Conclusion
The scope and claims of KR101475189 likely encompass innovative chemical entities and/or methods with specific therapeutic uses. The patent's breadth and positioning depend on the claim language, prior art landscape, and strategic filings. Its place within the overall patent landscape suggests a highly competitive environment, with strong incentives for patent holders to enforce rights and for competitors to innovate around.
Understanding the patent’s scope is vital for navigating freedom to operate, assessing infringement risks, and planning lifecycle strategies.
Key Takeaways
- Precise claim drafting is critical: Broad claims can provide extensive protection but entail higher enforcement and validity challenges.
- Patent landscape awareness informs strategic planning: Monitoring related patents helps avoid infringement and identify licensing opportunities.
- Global patent family expansion enhances commercial value: Filing internationally amplifies market exclusivity beyond South Korea.
- Regular patent validity assessments are necessary, considering advancing prior art and legal challenges.
- In-depth analysis of claim language enables stakeholders to design around or strengthen their patent positions.
FAQs
Q1: What is the significance of claim breadth in pharmaceutical patents like KR101475189?
Broad claims can secure extensive protection against competitors, but they are more vulnerable to invalidation if prior art is found. Narrow claims, while easier to defend, limit scope.
Q2: How does the patent landscape impact drug development in South Korea?
It determines freedom to operate, influences R&D investments, and guides licensing opportunities. A crowded landscape necessitates careful freedom-to-operate analyses.
Q3: Can the patent KR101475189 be extended beyond 20 years?
Generally, pharmaceutical patents are 20 years from filing, but extensions or SPCs—based on regulatory delays—can prolong effective market exclusivity.
Q4: What role does patent family analysis play in assessing patent strength?
It reveals the breadth of protection across jurisdictions, indicates strategic patenting efforts, and helps evaluate global market potential.
Q5: How do patent claim amendments during prosecution affect enforcement?
They can narrow or clarify scope, which influences infringement decisions and validity defenses. Strategic amendments are critical in patent litigation.
References
[1] South Korean Intellectual Property Office (KIPO): Patents Database
[2] WIPO PatentScope: International Patent Families
[3] Patent Documentation and Prosecution Records (Assumed from context)
[4] US and EPO Patent Portfolios for Comparative Landscape Analysis
